2010
DOI: 10.1016/j.ijfoodmicro.2010.09.003
|View full text |Cite
|
Sign up to set email alerts
|

Exopolysaccharide activities from probiotic bifidobacterium: Immunomodulatory effects (on J774A.1 macrophages) and antimicrobial properties

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
109
0
1

Year Published

2013
2013
2023
2023

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 166 publications
(112 citation statements)
references
References 33 publications
2
109
0
1
Order By: Relevance
“…Macrophages stimulated by enteric bacteria and/or their constituents (LPS) release pro-inflammatory cytokines and chemokines into the bloodstream (Okada et al, 2009). IL-10 is a 17-20 kDa glycoprotein and is a potent inhibitor for the production of pro-inflammatory cytokines such as TNF-a (Wu et al, 2010). In the present study, E. faecium, L. rhamnosus and LCS showed significant anti-inflammatory effect, as evidenced by the suppression of LPS-induced TNFa levels and upregulation of IL-10 levels (Okada et al, 2009).…”
Section: Discussionsupporting
confidence: 51%
See 1 more Smart Citation
“…Macrophages stimulated by enteric bacteria and/or their constituents (LPS) release pro-inflammatory cytokines and chemokines into the bloodstream (Okada et al, 2009). IL-10 is a 17-20 kDa glycoprotein and is a potent inhibitor for the production of pro-inflammatory cytokines such as TNF-a (Wu et al, 2010). In the present study, E. faecium, L. rhamnosus and LCS showed significant anti-inflammatory effect, as evidenced by the suppression of LPS-induced TNFa levels and upregulation of IL-10 levels (Okada et al, 2009).…”
Section: Discussionsupporting
confidence: 51%
“…Live probiotic bacteria residing in the intestine and their metabolites such as organic acids are reported to be effective in treating IBD (Okada et al, 2009;Wu et al, 2010). Previous evidence suggests that probiotic bacteria may have potential use as anti-inflammatory agents in Fig.…”
Section: Discussionmentioning
confidence: 99%
“…Probably, as the authors suggested, this effect could have been mediated through the formation of a protective "bifidobacterial biofilm" provided by the EPS of B. breve (8). Similarly, Wu et al (29) showed that the EPS purified from strain B. longum BCRC 1464 also showed antimicrobial activity against several pathogens. Besides, the cocultivation of macrophage J774A.1 cells with the heat-inactivated strain or with the purified EPS increased the release of anti-inflammatory IL-10; when cells were challenged with 100 ng/ml lipopolysaccharide (LPS), the purified EPS (at 5 g/ml) reduced the production of (proinflammatory) TNF-␣.…”
Section: Bioactivity Of Eps From Bifidobacteriummentioning
confidence: 98%
“…In concordance with these homeostatic effects, a study by Sengül et al (2006) demonstrated that EPS-producing bacteria were able to significantly attenuate the inflammation of an experimental colitis model, induced via intracolonic administration of acetic acid, in rats. Additionally, this is supported further by evidence at the cellular level, as murine macrophages challenged with various EPSs (isolated from strains of lactobacilli and bifidobacteria) demonstrate augmented release of both pro-and anti-inflammatory cytokines, such as TNF-a, IL-6 and IL-10 (Chabot et al, 2001;Bleau et al, 2010;Wu et al, 2010). The mitogenic activity of EPSs isolated from strains of lactobacilli and bifidobacteria is also well characterized, with studies showing the promotion of human, murine, porcine and bovine macrophage proliferation (Kitazawa et al, 1998;Chabot et al, 2001;Wu et al, 2010).…”
mentioning
confidence: 89%
“…Additionally, this is supported further by evidence at the cellular level, as murine macrophages challenged with various EPSs (isolated from strains of lactobacilli and bifidobacteria) demonstrate augmented release of both pro-and anti-inflammatory cytokines, such as TNF-a, IL-6 and IL-10 (Chabot et al, 2001;Bleau et al, 2010;Wu et al, 2010). The mitogenic activity of EPSs isolated from strains of lactobacilli and bifidobacteria is also well characterized, with studies showing the promotion of human, murine, porcine and bovine macrophage proliferation (Kitazawa et al, 1998;Chabot et al, 2001;Wu et al, 2010).With a large number of EPS-producing bacteria naturally residing in the intestine, it is surprising that very little research has been undertaken into the interaction of EPSs with the intestinal epithelial layer itself. Previous studies have investigated the potential of EPSs as antiproliferative or anticytoxic agents with intestinal epithelial cells (Ruas-Madiedo et al, 2010;Liu et al, 2011), but, the immunomodulatory effects of EPSs on these cells has largely been neglected in the literature.…”
mentioning
confidence: 89%